+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global In-Vitro Toxicology Testing Market by Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging), Method (Biochemical Assay, Cellular Assay, Ex-vivo), Application, End-User Industry - Forecast 2024-2030

  • PDF Icon

    Report

  • 198 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5532927
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The In-Vitro Toxicology Testing Market grew from USD 12.21 billion in 2023 to USD 13.49 billion in 2024. It is expected to continue growing at a CAGR of 10.90%, reaching USD 25.21 billion by 2030.

This innovative approach, used in pharmaceuticals, cosmetics, and the food industry, offers significant precision, repeatability, and speed benefits. The market is thriving due to advancements in testing methods, a rising ethos against animal testing, and the increased need for cost-effective safety measures. Potential growth areas lie in using in-vitro models in drug and therapeutic development, which closely mimic human biochemistry and minimize the occurrence of unsuccessful clinical trials. Further, the progress in genomics and proteomics presents considerable growth opportunities. The market, however, faces challenges such as the complexity of test data interpretation, the difficulty of replicating in-vivo conditions, and regulatory intricacies, all of which contribute to high operational costs. Future business growth hinges on focused research to enhance the predictive accuracy of in-vitro test systems while lowering costs. Collaborations with regulatory agencies for test recognition and approval advances in computational biology and genomics and innovations in 3D cell culture and organ-on-a-chip systems collectively drive market expansion, ensuring a broad consumer base is achieved while upholding consumer safety standards.

Regional Insights

The Americas, particularly the U.S., and Canada, spearheading the in vitro toxicology testing field due to high biomedical research demand from high chronic disease prevalence. Government initiatives and the robust presence of market leaders further bolster their position. Europe also leans towards in-vitro testing, with legislation including Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) law spurring investment into efficient and reliable testing methods, especially for hazard identification and risk assessment. Despite being nascent, the Middle East and Africa also demonstrate a high potential market, encouraged by the increased healthcare sector investment and the pressing need to comply with global health and safety regulations. Dynamic consumer demands in the Asia Pacific, including countries such as China, Japan, and India, propel the growth of in-vitro testing in this region. For example, China's funding for biomedical research is increasing, Japan benefits from a sturdy healthcare framework and notable pro-research policies, and healthcare investors are courting India's burgeoning economy. Global initiatives, patenting activities, and research advancements, such as the EU's Horizon 2020 project and China's National Natural Science Foundation funding, underscore the indispensable role of in-vitro toxicology testing.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the In-Vitro Toxicology Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • R&D initiatives for drug discovery and launch of novel agrochemicals and food additives
  • Utilization of in-vitro toxicology testing for evaluation of medical devices

Market Restraints

  • Technical limitations and inability to accurately replicate certain biological phenomena

Market Opportunities

  • Advancements in in-vitro toxicology testing and adoption of computational biology for analyzing toxicology data
  • Government programs to promote cruelty-free testing methods and develop novel toxicology assays

Market Challenges

  • Chances of drug approval failures with the current models.

Market Segmentation Analysis

  • Technology: Preference for in-vitro toxicology testing technology selection largely depends by specific research needs
  • Method: Cellular assays gained importance in toxicity, pharmacokinetics and pharmacodynamics in vitro toxicology testing
  • Application: Rising focus on improving testing methods while delivering accurate, reliable results catering to industry-specific requirements
  • End-Use: In vitro testing used vigorously in food and pharma sectors to ensure safety standards

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the In-Vitro Toxicology Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the In-Vitro Toxicology Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

LGC Clinical Diagnostics Acquires QC Product Maker Kova International

LGC Clinical Diagnostics acquired Kova International, Inc. This strategic move aims to expand its portfolio in the clinical quality control space. Kova develops and manufactures in vitro urinalysis and toxicology products for clinical laboratories. This strategic acquisition strengthens LGC's position in the market and enhances its ability to deliver comprehensive and reliable solutions to the clinical diagnostics industry.

ERBC Group Extends its Preclinical Expertise with the Acquisition of Oncofactory

ERBC Group acquired Oncofactory, a Contract Research Organization (CRO) specializing in efficacy testing and patient selection for clinical trials of anticancer treatments. Oncofactory utilizes an innovative Ovo model for these trials. This acquisition represents a significant milestone in ERBC Group's strategy to establish itself as a prominent independent non-clinical CRO in Europe. By incorporating Oncofactory's models, ERBC Group can offer scientifically relevant and regulatory-accepted models for drug and chemical discovery and development.

IIVS and Toxys Entered into an Agreement to Offer ToxTracker for In-Vitro Genetic Toxicity Evaluation

Toxys Inc. and the Institute for In Vitro Sciences (IIVS) entered a license agreement, allowing IIVS to offer the ToxTracker assay. This innovative stem cell-based reporter assay is specifically designed to identify genotoxic and potentially carcinogenic properties of drugs, chemicals, cosmetics, and other substances without animal testing. Through this agreement, IIVS and Toxys aim to contribute to developing safer and more effective products while reducing the reliance on animal testing.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the In-Vitro Toxicology Testing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Toxicology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioIVT LLC, Charles River Laboratories International, Inc., Creative Bioarray, ERBC Group, Eurofins Scientific SE, Evotec SE, F. Hoffmann-La Roche AG, Gentronix Limited, HD Biosciences Co., Ltd., INDIGO Biosciences, Inc., Inotiv, Inc., InSphero AG, Intertek Group PLC, Laboratory Corporation of America Holdings, LAUS GmbH, LGC Limited, Merck KGaA, Microbac Laboratories Inc., Oroxcell SAS, Promega Corporation, Qiagen N.V., SGS SA, Thermo Fisher Scientific Inc., Toxys, Inc., Vimta Labs Ltd., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Toxicology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

Method

  • Biochemical Assay
  • Cellular Assay
  • Ex-vivo
  • In Silico

Application

  • Dermal Toxicity
  • Endocrine Disruption
  • Occular Toxicity
  • Systemic Toxicology

End-User Industry

  • Chemicals
  • Cosmetic & Household Products
  • Food
  • Pharmaceuticals & Biopharmaceuticals

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. R&D initiatives for drug discovery and launch of novel agrochemicals and food additives
5.1.1.2. Utilization of in-vitro toxicology testing for evaluation of medical devices
5.1.2. Restraints
5.1.2.1. Technical limitations and inability to accurately replicate certain biological phenomena
5.1.3. Opportunities
5.1.3.1. Advancements in in-vitro toxicology testing and adoption of computational biology for analyzing toxicology data
5.1.3.2. Government programs to promote cruelty-free testing methods and develop novel toxicology assays
5.1.4. Challenges
5.1.4.1. Chances of drug approval failures with the current models.
5.2. Market Segmentation Analysis
5.2.1. Technology: Preference for in-vitro toxicology testing technology selection largely depends by specific research needs
5.2.2. Method: Cellular assays gained importance in toxicity, pharmacokinetics and pharmacodynamics in vitro toxicology testing
5.2.3. Application: Rising focus on improving testing methods while delivering accurate, reliable results catering to industry-specific requirements
5.2.4. End-Use: In vitro testing used vigorously in food and pharma sectors to ensure safety standards
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. In-Vitro Toxicology Testing Market, by Technology
6.1. Introduction
6.2. Cell Culture Technology
6.3. High Throughput Technology
6.4. Molecular Imaging
6.5. OMICS Technology
7. In-Vitro Toxicology Testing Market, by Method
7.1. Introduction
7.2. Biochemical Assay
7.3. Cellular Assay
7.4. Ex-vivo
7.5. In Silico
8. In-Vitro Toxicology Testing Market, by Application
8.1. Introduction
8.2. Dermal Toxicity
8.3. Endocrine Disruption
8.4. Occular Toxicity
8.5. Systemic Toxicology
9. In-Vitro Toxicology Testing Market, by End-User Industry
9.1. Introduction
9.2. Chemicals
9.3. Cosmetic & Household Products
9.4. Food
9.5. Pharmaceuticals & Biopharmaceuticals
10. Americas In-Vitro Toxicology Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific In-Vitro Toxicology Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa In-Vitro Toxicology Testing Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. LGC Clinical Diagnostics Acquires QC Product Maker Kova International
13.3.2. ERBC Group Extends its Preclinical Expertise with the Acquisition of Oncofactory
13.3.3. IIVS and Toxys Entered into an Agreement to Offer ToxTracker for In-Vitro Genetic Toxicity Evaluation
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. IN-VITRO TOXICOLOGY TESTING MARKET RESEARCH PROCESS
FIGURE 2. IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IN-VITRO TOXICOLOGY TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2023 VS 2030 (%)
FIGURE 14. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. IN-VITRO TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. IN-VITRO TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. IN-VITRO TOXICOLOGY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY HIGH THROUGHPUT TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY BIOCHEMICAL ASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELLULAR ASSAY, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CELLULAR ASSAY, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY EX-VIVO, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY EX-VIVO, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY IN SILICO, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DERMAL TOXICITY, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY DERMAL TOXICITY, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY ENDOCRINE DISRUPTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCCULAR TOXICITY, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY OCCULAR TOXICITY, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SYSTEMIC TOXICOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY SYSTEMIC TOXICOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CHEMICALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY CHEMICALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC & HOUSEHOLD PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COSMETIC & HOUSEHOLD PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY FOOD, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY FOOD, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS & BIOPHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICALS & BIOPHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 73. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 74. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 75. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 76. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 77. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 78. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 79. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 80. CANADA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 81. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 82. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 83. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 84. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 85. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 86. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 87. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 88. MEXICO IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 117. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 118. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 119. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 120. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 121. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 122. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 123. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 124. CHINA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 125. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 126. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 127. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 128. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 129. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 132. INDIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 141. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 142. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 143. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 144. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 145. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 146. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 147. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 148. JAPAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 189. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 190. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 191. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 192. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 193. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 196. THAILAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 215. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 216. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 217. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 218. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 219. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 220. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 221. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 222. DENMARK IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 223. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 224. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 225. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 226. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 227. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 230. EGYPT IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 231. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 232. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 233. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 234. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 235. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 238. FINLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 239. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 240. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 241. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 242. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 243. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 244. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 245. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 246. FRANCE IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 247. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 248. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 249. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 250. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 251. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 254. GERMANY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 263. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 264. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 265. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 266. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 267. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 268. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 269. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 270. ITALY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 287. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 288. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 289. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 290. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 291. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 292. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 293. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 294. NORWAY IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 295. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 296. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 297. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 298. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 299. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 302. POLAND IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 303. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 304. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 305. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 306. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 307. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 308. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 309. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 310. QATAR IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2024-2030 (USD MILLION)
TABLE 315. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 316. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 317. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2018-2023 (USD MILLION)
TABLE 318. RUSSIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY END-USER INDUSTRY, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA IN-VITRO TOXICOLOGY TESTING MARKET SIZE, BY

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioIVT LLC
  • Charles River Laboratories International, Inc.
  • Creative Bioarray
  • ERBC Group
  • Eurofins Scientific SE
  • Evotec SE
  • F. Hoffmann-La Roche AG
  • Gentronix Limited
  • HD Biosciences Co., Ltd.
  • INDIGO Biosciences, Inc.
  • Inotiv, Inc.
  • InSphero AG
  • Intertek Group PLC
  • Laboratory Corporation of America Holdings
  • LAUS GmbH
  • LGC Limited
  • Merck KGaA
  • Microbac Laboratories Inc.
  • Oroxcell SAS
  • Promega Corporation
  • Qiagen N.V.
  • SGS SA
  • Thermo Fisher Scientific Inc.
  • Toxys, Inc.
  • Vimta Labs Ltd.
  • WuXi AppTec

Methodology

Loading
LOADING...

Table Information